CARISMA Therapeutics Inc (OTCPK:CARM)
$ 0.0081 +0.00010 (+1.25%) Market Cap: 339,000.00 Enterprise Value: -1.68 Mil PE Ratio: 0.04 PB Ratio: 0 GF Score: 0/100

Sesen Bio, Inc. - Special Call Transcript

Feb 16, 2021 / 01:00PM GMT
Operator

Thank you for standing by, and welcome to the Sesen Bio Business Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today, Ms. Erin Clark, VP of Corporate Strategy and Investor Relations. Thank you. Please go ahead, ma'am.

Erin Clark
Sesen Bio, Inc. - VP of Corporate Strategy & IR

Thank you, and good morning, everyone. Welcome to today's conference call. Joining me today is Dr. Thomas Cannell, President and Chief Executive Officer.

For today's call, we will have about 5 minutes for prepared remarks and then we will open the line for questions and answers.

Earlier this morning, we issued a press release outlining some of the highlights that will be covered today. The press release to which we will refer is available in the Investors section of the company's website at sesenbio.com.

I would like to remind you that today's discussion will include forward-looking statements related to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot